Detalhe da pesquisa
1.
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.
Cell
; 184(11): 2988-3005.e16, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019793
2.
Dual Chromatin and Cytoskeletal Remodeling by SETD2.
Cell
; 166(4): 950-962, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27518565
3.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708940
4.
Noninvasive detection of any-stage cancer using free glycosaminoglycans.
Proc Natl Acad Sci U S A
; 119(50): e2115328119, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469776
5.
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
N Engl J Med
; 385(22): 2036-2046, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818478
6.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
J Natl Compr Canc Netw
; 22(1): 4-16, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394781
7.
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy.
Angiogenesis
; 26(2): 279-293, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459240
8.
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Oncologist
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035767
9.
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.
BJU Int
; 129(5): 610-620, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228889
10.
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(1): 71-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991070
11.
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.
Lancet Oncol
; 22(12): 1732-1739, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717797
12.
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Cancer
; 127(21): 3957-3966, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343338
13.
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies.
Oncologist
; 26(6): 476-482, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792094
14.
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.
BMC Cancer
; 21(1): 904, 2021 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34364385
15.
Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease.
World J Urol
; 39(7): 2409-2415, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936333
16.
Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Int J Mol Sci
; 22(5)2021 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668731
17.
Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events.
Br J Cancer
; 123(6): 898-904, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587360
18.
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis.
Oncologist
; 25(3): 252-258, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162795
19.
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 18(9): 1160-1170, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886895
20.
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).
Oncologist
; 24(4): 491-497, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867244